Neural stem cells exposed to BrdU lose their global DNA methylation and undergo astrocytic differentiation
暂无分享,去创建一个
[1] F. D. D. Fagagna,et al. Terminally differentiated astrocytes lack DNA damage response signaling and are radioresistant but retain DNA repair proficiency , 2011, Cell Death and Differentiation.
[2] S. Couillard-Després,et al. The dark side of BrdU in neural stem cell biology: detrimental effects on cell cycle, differentiation and survival , 2011, Cell and Tissue Research.
[3] Teresa T. Martin-Carreras,et al. Ethynyldeoxyuridine (EdU) suppresses in vitro population expansion and in vivo tumor progression of human glioblastoma cells , 2011, Journal of Neuro-Oncology.
[4] K. Kang,et al. DNA Methyltransferase Controls Stem Cell Aging by Regulating BMI1 and EZH2 through MicroRNAs , 2011, PloS one.
[5] Yi Zhang,et al. Active DNA demethylation: many roads lead to Rome , 2010, Nature Reviews Molecular Cell Biology.
[6] A. Breiling,et al. Nucleoside Drugs Induce Cellular Differentiation by Caspase-Dependent Degradation of Stem Cell Factors , 2010, PloS one.
[7] Saswati Banerjee,et al. DNA methyltransferase inhibition induces mouse embryonic stem cell differentiation into endothelial cells. , 2010, Experimental cell research.
[8] Paul A. Khavari,et al. DNMT1 Maintains Progenitor Function in Self-Renewing Somatic Tissue , 2010, Nature.
[9] Dominic T. Schomberg,et al. Cellular Epigenetic Modifications of Neural Stem Cell Differentiation , 2009, Cell transplantation.
[10] Justin C. Grindley,et al. Tumour-initiating cells: challenges and opportunities for anticancer drug discovery , 2009, Nature Reviews Drug Discovery.
[11] G. Biella,et al. An optimized experimental strategy for efficient conversion of embryonic stem (ES)-derived mouse neural stem (NS) cells into a nearly homogeneous mature neuronal population , 2009, Neurobiology of Disease.
[12] D. Steindler,et al. Bromodeoxyuridine Induces Senescence in Neural Stem and Progenitor Cells , 2008, Stem cells.
[13] E. Laywell,et al. Bromodeoxyuridine inhibits cancer cell proliferation in vitro and in vivo. , 2008, Neoplasia.
[14] T. Mikkelsen,et al. Genome-scale DNA methylation maps of pluripotent and differentiated cells , 2008, Nature.
[15] F. D. D. Fagagna. Living on a break: cellular senescence as a DNA-damage response , 2008, Nature Reviews Cancer.
[16] J. Kohyama,et al. Epigenetic mechanisms regulating fate specification of neural stem cells , 2008, Philosophical Transactions of the Royal Society B: Biological Sciences.
[17] J. Issa. DNA methylation as a therapeutic target in cancer. , 2008, Clinical cancer research : an official journal of the American Association for Cancer Research.
[18] K. Nakai,et al. Genome-wide demethylation during neural differentiation of P19 embryonal carcinoma cells , 2008, Journal of Human Genetics.
[19] Keith D. Robertson,et al. DNA Methylation Inhibitor 5-Aza-2′-Deoxycytidine Induces Reversible Genome-Wide DNA Damage That Is Distinctly Influenced by DNA Methyltransferases 1 and 3B , 2007, Molecular and Cellular Biology.
[20] S. O'Dea,et al. 5-Bromo-2-deoxyuridine activates DNA damage signalling responses and induces a senescence-like phenotype in p16-null lung cancer cells , 2007, Anti-cancer drugs.
[21] Austin G Smith,et al. Tripotential Differentiation of Adherently Expandable Neural Stem (NS) Cells , 2007, PloS one.
[22] P. Taupin. BrdU immunohistochemistry for studying adult neurogenesis: Paradigms, pitfalls, limitations, and validation , 2007, Brain Research Reviews.
[23] Austin G Smith,et al. Niche-Independent Symmetrical Self-Renewal of a Mammalian Tissue Stem Cell , 2005, PLoS biology.
[24] K. Ghoshal,et al. 5-Aza-Deoxycytidine Induces Selective Degradation of DNA Methyltransferase 1 by a Proteasomal Pathway That Requires the KEN Box, Bromo-Adjacent Homology Domain, and Nuclear Localization Signal , 2005, Molecular and Cellular Biology.
[25] S. Scherer,et al. Early BrdU-responsive genes constitute a novel class of senescence-associated genes in human cells. , 2005, Experimental cell research.
[26] D. Peterson,et al. Stem cell proliferative history in tissue revealed by temporal halogenated thymidine analog discrimination , 2005, Nature Methods.
[27] S. Katsuma,et al. Role of Chk1 and Chk2 in Ara‐C‐induced differentiation of human leukemia K562 cells , 2005, Genes to cells : devoted to molecular & cellular mechanisms.
[28] A. Jeltsch,et al. Biochemistry and biology of mammalian DNA methyltransferases , 2004, Cellular and Molecular Life Sciences CMLS.
[29] F. Doetsch,et al. The glial identity of neural stem cells , 2003, Nature Neuroscience.
[30] Austin G Smith,et al. Conversion of embryonic stem cells into neuroectodermal precursors in adherent monoculture , 2003, Nature Biotechnology.
[31] T. Kinsella,et al. Targeting DNA mismatch repair for radiosensitization. , 2001, Seminars in Radiation Oncology.
[32] S. Kaul,et al. 5-Bromodeoxyuridine induces senescence-like phenomena in mammalian cells regardless of cell type or species. , 1999, Journal of biochemistry.
[33] F. Gage,et al. Neurogenesis in the adult human hippocampus , 1998, Nature Medicine.
[34] T. Palmer,et al. Neurogenesis in the dentate gyrus of the adult rat: age-related decrease of neuronal progenitor proliferation , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[35] C. Lois,et al. Proliferating subventricular zone cells in the adult mammalian forebrain can differentiate into neurons and glia. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[36] Charles B. Wilson,et al. Variability in the proliferative potential of human gliomas , 1989, Journal of Neuro-Oncology.
[37] M. Miller,et al. Bromodeoxyuridine immunohistochemical determination of the lengths of the cell cycle and the DNA-synthetic phase for an anatomically defined population , 1989, Journal of neurocytology.
[38] E. Kaufman. The role of deoxyribonucleotide metabolism in 5-bromo-2'-deoxyuridine mutagenesis in mammalian cells. , 1988, Mutation research.
[39] R. Lasken,et al. The biochemical basis of 5-bromouracil-induced mutagenesis. Heteroduplex base mispairs involving bromouracil in G x C----A x T and A x T----G x C mutational pathways. , 1984, The Journal of biological chemistry.
[40] H. Gratzner,et al. Monoclonal antibody to 5-bromo- and 5-iododeoxyuridine: A new reagent for detection of DNA replication. , 1982, Science.
[41] R. Davidson,et al. Bromodeoxyuridine mutagenesis in mammalian cells is related to deoxyribonucleotide pool imbalance , 1981, Molecular and cellular biology.
[42] R. H. Stellwagen,et al. 5-Methylcytosine content of rat hepatoma DNA substituted with bromodeoxyuridine. , 1977, The Journal of biological chemistry.
[43] W. Rutter,et al. Increased thermal stability of chromatin containing 5-bromodeoxyuridine-substituted DNA. , 1974, Proceedings of the National Academy of Sciences of the United States of America.
[44] C. Palmer. 5-bromodeoxyuridine-induced constrictions in human chromosomes. , 1970, Canadian journal of genetics and cytology. Journal canadien de genetique et de cytologie.
[45] J. Altman,et al. Autoradiographic and histological evidence of postnatal hippocampal neurogenesis in rats , 1965, The Journal of comparative neurology.
[46] E. Saksela,et al. THE EFFECT OF 5-BROMODEOXYURIDINE ON HUMAN CHROMOSOMES. , 1964, Experimental cell research.